Neubauer, Blake Lee <br/><br/>
The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.  [electronic resource] 

 -  Cancer research  Sep 2003 
 - 6056-62 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Body Weight--drug effects<br/>Cell Division--drug effects<br/>Disease Models, Animal<br/>Estrogen Receptor alpha<br/>Estrogen Receptor beta<br/>Genitalia, Male--drug effects<br/>Luciferases--antagonists & inhibitors<br/>Lung Neoplasms--prevention & control<br/>Lymphatic Metastasis<br/>Male<br/>Organ Size--drug effects<br/>Prostatic Neoplasms--drug therapy<br/>Pyrrolidines--metabolism<br/>Rats<br/>Receptors, Androgen--biosynthesis<br/>Receptors, Estrogen--biosynthesis<br/>Selective Estrogen Receptor Modulators--metabolism<br/>Testis--anatomy & histology